Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
T Meejun, K Srisurapanont, K Manothummetha… - Blood Advances, 2023 - Elsevier
Immunogenicity of SARS-CoV-2 vaccination is diminished in hematopoietic stem cell
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
[HTML][HTML] Understanding the impact of COVID-19 on chronic lymphocytic leukemia (CLL) caregiving and related resource needs
Chronic lymphocytic leukemia (CLL) caregivers play a central role in disease management—
a role that has been heightened during the COVID-19 pandemic given the healthcare …
a role that has been heightened during the COVID-19 pandemic given the healthcare …
[HTML][HTML] Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection
PT Diamantopoulos, CN Kontandreopoulou… - Annals of …, 2022 - Springer
Patients with chronic lymphocytic leukemia (CLL) show suboptimal responses to the
vaccines against SARS-CoV-2; it has been shown though that a booster dose of the …
vaccines against SARS-CoV-2; it has been shown though that a booster dose of the …
[HTML][HTML] Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia
AA Komissarov, M Kislova, IA Molodtsov… - International Journal of …, 2022 - mdpi.com
The clinical course of the new coronavirus disease 2019 (COVID-19) has shown that
patients with chronic lymphocytic leukemia (CLL) are characterized by a high mortality rate …
patients with chronic lymphocytic leukemia (CLL) are characterized by a high mortality rate …
[HTML][HTML] Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID …
S Rodríguez-Mora, M Corona, M Solera Sainero… - Cancers, 2023 - mdpi.com
Simple Summary Individuals with chronic myeloid leukemia (CML) are different from other
individuals with oncohematological disease (OHD) because they receive treatment with …
individuals with oncohematological disease (OHD) because they receive treatment with …
Biomarkers of Hypercoagulability in COVID-19
H Wada - Journal of Clinical Medicine, 2023 - mdpi.com
Biomarkers of Hypercoagulability in COVID-19 Page 1 Citation: Wada, H. Biomarkers of
Hypercoagulability in COVID-19. J. Clin. Med. 2023, 12, 3525. https:// doi.org/10.3390/jcm12103525 …
Hypercoagulability in COVID-19. J. Clin. Med. 2023, 12, 3525. https:// doi.org/10.3390/jcm12103525 …
[PDF][PDF] Supplement Online Content
O MEDLINE - scienceopen.com
8.(BNT162b2 or Pfizer or BioNTech or Comirnaty or Tozinameran). mp. 9.(CoronaVac or
Sinovac or PiCoVacc). mp. 10.(mRNA-1273 or Moderna or Elasomeran). mp. 11.((WIV04 …
Sinovac or PiCoVacc). mp. 10.(mRNA-1273 or Moderna or Elasomeran). mp. 11.((WIV04 …